Parth Sharma

@ParthDSharma

IM Resident @umkcIM via @aiims_newdelhi & former research trainee @theNCI Hem-Onc fellow @VCUHealth @VCUMassey Passionate about Global Oncology

Katılım Eylül 2021

232 Takip Edilen100 Takipçiler

Parth Sharma@ParthDSharma·5 Haz

Had a wonderful time presenting our research highlighting the efficacy of #immunecheckpointinhibitors in advanced lung LCNEC at #ASCO25. Grateful to my mentor @anuj_shrestha11 for his guidance and to the co-authors for their support. @ASCO @umkcIM @KrityaMangesh

English

443

Parth Sharma retweetledi

Marc Roth@MarcRothMD·1 Haz

#ASCO25 Day 2: so proud of our two stellar residents, soon to be fellows! @Meddoc77 (Himil Mahadevia) and Parth Sharma. Congrats on the posters, can’t wait to see what your futures hold! @SLCI_KC @saintlukeskc

English

999

Parth Sharma@ParthDSharma·3 Nis

Thrilled to present our research at the #NCCN2025!! Grateful to my mentor for his guidance and the co-authors for their support. @umkcIM @anuj_shrestha11 @PiyushNathani3 @Rohit_nathani1 @NCCN

English

484

Parth Sharma retweetledi

OncoDaily GI@OncoDailyGI·29 Oca

The efficacy of HER-2 targeted therapies in biliary tract cancers - @ParthDSharma @ASCO oncodaily.com/url/234115 #Cancer #GIOnc #GI25 #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

English

532

Parth Sharma@ParthDSharma·5 Şub

@sciqst Thank you!!! Our study found that HER-2 targeted MOAs, ADCs, and bispecific antibodies have demonstrated promising results in BTCs.

English

Raffaele Di Giacomo, PhD@sciqst·27 Oca

Congratulations on presenting your research! The focus on HER-2 targeted therapies is intriguing, especially for biliary tract cancers. What were the key takeaways in terms of efficacy from your study? Also, how do you see this impacting future clinical practices? For anyone interested in diving deeper into biomedical research questions, sciqst.com is a fantastic resource. It’s a one-stop platform for generating comprehensive biomedical reviews. #Medicine #BiliaryCancer #Her2Therapy

English

Parth Sharma@ParthDSharma·27 Oca

Thrilled to present our research at @ASCO #GI25 highlighting the efficacy of HER-2 targeted therapies in #biliarytractcancers!!! Grateful to my mentor @MarcRothMD for his guidance and all the co-authors for their support. @KrityaMangesh @umkcIM @SLCI_KC #MedTwitter

English

1.6K

Parth Sharma retweetledi

Himil Mahadevia@Meddoc77·20 Oca

Happy to share our literature review on current and upcoming pharmacologic drugs for Sickle cell disease published in Annals of Hematology - link.springer.com/article/10.100… @umkcIM @BPonvilawan @Ujjwal_Madan1 @ParthDSharma @anuj_shrestha11 #Hematology #HemeTwitter #MedTwitter #MedEd

English

715

Parth Sharma@ParthDSharma·10 Ara

@BPonvilawan @VCUHealth @Priyanka031996 @umkcIM @SLCI_KC @aiims_newdelhi @VCUMassey @HemOncFellows Thank you!!!

English

Ben Ponvilawan, MD, MS@BPonvilawan·10 Ara

@ParthDSharma @VCUHealth @Priyanka031996 @umkcIM @SLCI_KC @aiims_newdelhi @VCUMassey @HemOncFellows Congratulations!

English

Parth Sharma@ParthDSharma·9 Ara

Dreams do come true!!! Matched to the Hem-Onc fellowship at @VCUHealth, one of the NCI-designated comprehensive cancer centers. Grateful to my wife @Priyanka031996, family, friends, and mentors at @umkcIM, @SLCI_KC, and @aiims_newdelhi. @VCUMassey #Match2025 @HemOncFellows #GlobalOncology